LEO Pharma, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration (FDA) has approved ANZUPGO ® (delgocitinib) cream (20 mg/g) for the topical treatment of ...

University of Gothenburg. (2019, May 15). Combination therapy advisable for bowel disorder IBS. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2019 / 05 / 190515102143.htm ...